AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Elevance Health Welcomes Steve Collis as New Board Director
ByAinvest
Monday, Jul 28, 2025 9:10 pm ET1min read
Elevance Health's board of directors welcomes Steve Collis, a global healthcare executive, as a new director, effective August 1. He will serve on the Audit and Finance Committees, enhancing the board's industry expertise and financial oversight capabilities. His addition is part of the board's ongoing commitment to governance excellence and strategy refresh.
Elevance Health (NYSE: ELV) has announced the addition of Steve Collis to its board of directors, effective August 1, 2025. Collis, a highly regarded global healthcare executive, will serve on the Audit and Finance Committees, enhancing the board's industry expertise and financial oversight capabilities. His appointment reflects the company's ongoing commitment to governance excellence and strategic refresh [1].Collis brings a distinguished record of leadership, transformation, and operational excellence. He currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), a role he assumed in 2024 after a long tenure as President and CEO. During his 13-year tenure as CEO, Collis led Cencora through significant strategic transformation, expanding its global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain [1].
Ramey Peru, Chair of the Elevance Health Board of Directors, stated, "Steve brings deep experience in healthcare operations and long-term value creation, aligning well with our strategic objectives. His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve" [1].
Elevance Health, a lifetime, trusted health partner, supports consumers, families, and communities across the entire healthcare journey. The company serves over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions [1].
References:
[1] https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director
[2] https://www.morningstar.com/news/business-wire/20250728510661/elevance-health-board-welcomes-steve-collis-as-new-director-reflecting-ongoing-commitment-to-governance-excellence
[3] https://www.businesswire.com/news/home/20250728510661/en/Elevance-Health-Board-Welcomes-Steve-Collis-as-New-Director-Reflecting-Ongoing-Commitment-to-Governance-Excellence
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet